Spectral.F7®Efficacy booster agent for hair is first with astressin-B peptide

Now men and women in treatment for thinning hair can add astressin-B, a complex new peptide, to maximize hair-follicle benefits, because Spectral.F7 is the first solution to incorporate this protein fragment for human use in a topical booster agent. Spectral.F7 augments primary therapies like Spectral.DNC-N® or minoxidil, and it can serve as an effective stand-alone treatment in early stages of thinning. ◊*

In a recent clinical trial, the astressin-B peptide:1

  • Blocks receptors for corticotropin-releasing factor, involved in the stress response, in laboratory animals. ◊* Read more
  • Influences hair health when stress hormones are over-expressed.◊* Read more
  • Performs well as a stand-alone therapy to treat stress-induced cases.◊* Read more

Results from the trial mean that astressin-B offers a powerful new mechanism of action to treat atrophic follicles.◊*

As other brands begin their research into this powerful peptide technology, DS Laboratories offers an astressin-B topical booster today.


[*] Results are not guaranteed, individual results may vary.

[◊] This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

[1] CRF receptor antagonist astressin-B reverses and prevents alopecia in CRF over-expressing mice.